Shares of Veracyte Inc. (VCYT) reached a 52-week high of $42.99 during intraday yesterday, reflecting investor optimism surrounding the company's ongoing developments.Veracyte, a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity, recently reported strong third-quarter results and raised its 2024 revenue outlook.For the third quarter of 2024, the company rep...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.